INS and diabetic kidney disease: GLP-1 improves insulin sensitivity, facilitates glucose uptake, and regulates lipid metabolism, thereby alleviating glycolipid metabolic disturbances commonly associated with hyperglycemia and hyperlipidemia in DKD (139, 140).